[1]
“Mesenchymal Stem Cells Ameliorate Lipid Metabolism while Reducing Blood Glucose in Streptozotocin (STZ)-Induced Diabetes Mellitus and High Fat Diet Induced Obesity”, ijmsdr, vol. 8, no. 1, Apr. 2024, doi: 10.32553/ijmsdr.v8i1.1019.